{
    "medicine_id": "10f688c88db280f755b8cfd19fc7ce4270643b3f",
    "platform_id": "DB05259",
    "metadata": {
        "name": "Copaxone 20 mg Solution",
        "composition": "20 mg Glatiramer",
        "clinical_particulars": {
            "therapeutic_indications": "For reduction of the frequency of relapses in patients with Relapsing Remitting Multiple Sclerosis",
            "contraindications": {
                "disease": "Adverse reactions include injection site reactions vasodilatation chest pain asthenia infection pain nausea arthralgia anxiety and hypertonia",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Glatiramer acetate was originally designed to mimic a protein in myelin called myelin basic protein with the intention of inducing EAE an animal model of MS Quite to the contrary it was found to suppress the disease and as a result came to be trialed in human MS There is some evidence that Glatiramer acetate converts the body s immune response from a Th1 type to a Th2 one promotes suppressor T cells or acts as an altered peptide ligand Studies in animals and in vitro systems suggest that upon its administration glatiramer acetate specific suppressor T cells are induced and activated in the periphery Some fraction of the injected material either intact or partially hydrolyzed is presumed to enter the lymphatic circulation enabling it to reach regional lymph nodes and some may enter the systemic circulation intact",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06643",
                        "description": "The risk or severity of adverse effects can be increased when Denosumab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The risk or severity of adverse effects can be increased when Etanercept is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2a is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n1 is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n3 is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2b is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The risk or severity of adverse effects can be increased when Anakinra is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The risk or severity of adverse effects can be increased when Interferon gamma 1b is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2a Recombinant is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of adverse effects can be increased when Aldesleukin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The risk or severity of adverse effects can be increased when Adalimumab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The risk or severity of adverse effects can be increased when Pegaspargase is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of adverse effects can be increased when Infliximab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The risk or severity of adverse effects can be increased when Interferon beta 1b is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfacon 1 is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of adverse effects can be increased when Rituximab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00074",
                        "description": "The risk or severity of adverse effects can be increased when Basiliximab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00075",
                        "description": "The risk or severity of adverse effects can be increased when Muromonab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00092",
                        "description": "The risk or severity of adverse effects can be increased when Alefacept is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00095",
                        "description": "The risk or severity of adverse effects can be increased when Efalizumab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00098",
                        "description": "The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin rabbit is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2b is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00111",
                        "description": "The risk or severity of adverse effects can be increased when Daclizumab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of adverse effects can be increased when Bevacizumab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of adverse effects can be increased when Phenylalanine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The risk or severity of adverse effects can be increased when Flunisolide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of adverse effects can be increased when Bortezomib is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of adverse effects can be increased when Cladribine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of adverse effects can be increased when Carmustine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of adverse effects can be increased when Amsacrine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "The risk or severity of adverse effects can be increased when Bleomycin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of adverse effects can be increased when Chlorambucil is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of adverse effects can be increased when Raltitrexed is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of adverse effects can be increased when Mitomycin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The risk or severity of adverse effects can be increased when Bexarotene is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of adverse effects can be increased when Vindesine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of adverse effects can be increased when Floxuridine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of adverse effects can be increased when Indomethacin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of adverse effects can be increased when Tioguanine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of adverse effects can be increased when Vinorelbine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of adverse effects can be increased when Sorafenib is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of adverse effects can be increased when Streptozocin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "The risk or severity of adverse effects can be increased when Trifluridine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of adverse effects can be increased when Gemcitabine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of adverse effects can be increased when Betamethasone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The risk or severity of adverse effects can be increased when Teniposide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of adverse effects can be increased when Epirubicin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of adverse effects can be increased when Lenalidomide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of adverse effects can be increased when Altretamine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of adverse effects can be increased when Zidovudine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of adverse effects can be increased when Cisplatin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of adverse effects can be increased when Vincristine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of adverse effects can be increased when Fluorouracil is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of adverse effects can be increased when Pentostatin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of adverse effects can be increased when Methotrexate is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when Carbamazepine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of adverse effects can be increased when Vinblastine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Linezolid is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of adverse effects can be increased when Imatinib is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of adverse effects can be increased when Triamcinolone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of adverse effects can be increased when Clofarabine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The risk or severity of adverse effects can be increased when Prednisone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The risk or severity of adverse effects can be increased when Pemetrexed is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of adverse effects can be increased when Daunorubicin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The risk or severity of adverse effects can be increased when Irinotecan is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The risk or severity of adverse effects can be increased when Methimazole is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The risk or severity of adverse effects can be increased when Etoposide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The risk or severity of adverse effects can be increased when Dacarbazine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of adverse effects can be increased when Temozolomide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of adverse effects can be increased when Penicillamine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The risk or severity of adverse effects can be increased when Prednisolone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The risk or severity of adverse effects can be increased when Sirolimus is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of adverse effects can be increased when Azacitidine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of adverse effects can be increased when Carboplatin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of adverse effects can be increased when Dactinomycin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of adverse effects can be increased when Cytarabine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The risk or severity of adverse effects can be increased when Azathioprine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of adverse effects can be increased when Doxorubicin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of adverse effects can be increased when Busulfan is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The risk or severity of adverse effects can be increased when Topotecan is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of adverse effects can be increased when Thalidomide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of adverse effects can be increased when Melphalan is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of adverse effects can be increased when Fludarabine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of adverse effects can be increased when Flucytosine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of adverse effects can be increased when Capecitabine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The risk or severity of adverse effects can be increased when Trilostane is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Procarbazine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of adverse effects can be increased when Idarubicin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of adverse effects can be increased when Ifosfamide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01196",
                        "description": "The risk or severity of adverse effects can be increased when Estramustine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of adverse effects can be increased when Lomustine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The risk or severity of adverse effects can be increased when Budesonide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of adverse effects can be increased when Paclitaxel is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of adverse effects can be increased when Dexamethasone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of adverse effects can be increased when Docetaxel is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of adverse effects can be increased when Dasatinib is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01257",
                        "description": "The risk or severity of adverse effects can be increased when Eculizumab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of adverse effects can be increased when Decitabine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of adverse effects can be increased when Sunitinib is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of adverse effects can be increased when Nelarabine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The risk or severity of adverse effects can be increased when Abatacept is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The risk or severity of adverse effects can be increased when Corticotropin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The risk or severity of adverse effects can be increased when Paramethasone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The risk or severity of adverse effects can be increased when Colchicine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The risk or severity of adverse effects can be increased when Ciclesonide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01423",
                        "description": "The risk or severity of adverse effects can be increased when Stepronin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The risk or severity of adverse effects can be increased when Everolimus is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01816",
                        "description": "The risk or severity of adverse effects can be increased when Castanospermine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of adverse effects can be increased when Vorinostat is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB02806",
                        "description": "The risk or severity of adverse effects can be increased when 2 Methoxyethanol is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB03523",
                        "description": "The risk or severity of adverse effects can be increased when Brequinar is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of adverse effects can be increased when Thiotepa is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The risk or severity of adverse effects can be increased when Aldosterone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The risk or severity of adverse effects can be increased when Ixabepilone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of adverse effects can be increased when Nilotinib is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The risk or severity of adverse effects can be increased when Pirfenidone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The risk or severity of adverse effects can be increased when Afelimomab is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of adverse effects can be increased when Belinostat is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of adverse effects can be increased when Trabectedin is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05260",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Gallium nitrate"
                    },
                    {
                        "drugbank-id": "DB05459",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Briakinumab"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Human interferon omega 1"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06612",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Mepolizumab"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06662",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Abetimus"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB06681",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Belatacept"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Bendamustine"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Pralatrexate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Ruxolitinib"
                    },
                    {
                        "drugbank-id": "DB08879",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Belimumab"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08908",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Dimethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09033",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Vedolizumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Ibrutinib"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Idelalisib"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Olaparib"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Tixocortol"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB09312",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Antilymphocyte immunoglobulin horse"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluprednisolone"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Melengestrol"
                    },
                    {
                        "drugbank-id": "DB11569",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Ixekizumab"
                    },
                    {
                        "drugbank-id": "DB11580",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Ravulizumab"
                    },
                    {
                        "drugbank-id": "DB11616",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Pirarubicin"
                    },
                    {
                        "drugbank-id": "DB11693",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Voclosporin"
                    },
                    {
                        "drugbank-id": "DB11708",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Peficitinib"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Sarilumab"
                    },
                    {
                        "drugbank-id": "DB11776",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Brodalumab"
                    },
                    {
                        "drugbank-id": "DB11803",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Sirukumab"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Baricitinib"
                    },
                    {
                        "drugbank-id": "DB11834",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Guselkumab"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB11988",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Ocrelizumab"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Triptolide"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Ozanimod"
                    },
                    {
                        "drugbank-id": "DB12617",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Mizoribine"
                    },
                    {
                        "drugbank-id": "DB12692",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Gusperimus"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB12902",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Trofosfamide"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Doxifluridine"
                    },
                    {
                        "drugbank-id": "DB12991",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Deoxyspergualin"
                    },
                    {
                        "drugbank-id": "DB12996",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Acteoside"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13068",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with 9 N methyl L isoleucine cyclosporin A"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluocortin"
                    },
                    {
                        "drugbank-id": "DB13241",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Begelomab"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluperolone"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluclorolone"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14219",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Monomethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB14762",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Risankizumab"
                    },
                    {
                        "drugbank-id": "DB14919",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Rozanolixizumab"
                    },
                    {
                        "drugbank-id": "DB15253",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Bleselumab"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The risk or severity of adverse effects can be increased when Fluocinonide is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Hydrocortisone butyrate"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The risk or severity of adverse effects can be increased when Desoximetasone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The risk or severity of adverse effects can be increased when Mometasone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "The risk or severity of adverse effects can be increased when Fluorometholone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB00108",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Natalizumab"
                    },
                    {
                        "drugbank-id": "DB00337",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Roflumilast may increase the immunosuppressive activities of Glatiramer"
                    },
                    {
                        "drugbank-id": "DB06688",
                        "description": "The therapeutic efficacy of Sipuleucel T can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Leflunomide"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "Glatiramer may increase the immunosuppressive activities of Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "Trastuzumab may increase the neutropenic activities of Glatiramer"
                    },
                    {
                        "drugbank-id": "DB08868",
                        "description": "Glatiramer may increase the immunosuppressive activities of Fingolimod"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may increase the immunosuppressive activities of Glatiramer"
                    },
                    {
                        "drugbank-id": "DB04914",
                        "description": "The therapeutic efficacy of G17DT can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05144",
                        "description": "The therapeutic efficacy of PEV3A can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05325",
                        "description": "The therapeutic efficacy of INGN 225 can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05374",
                        "description": "The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05440",
                        "description": "The therapeutic efficacy of SRP 299 can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05942",
                        "description": "The therapeutic efficacy of GI 5005 can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB06400",
                        "description": "The therapeutic efficacy of Vitespen can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB06584",
                        "description": "The therapeutic efficacy of TG4010 can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB09057",
                        "description": "The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10062",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen B can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10076",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10276",
                        "description": "The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10283",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen A can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10342",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10583",
                        "description": "The therapeutic efficacy of Clostridium tetani toxoid antigen formaldehyde inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10584",
                        "description": "The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen formaldehyde inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10600",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10769",
                        "description": "The therapeutic efficacy of Japanese encephalitis virus strain sa 14 14 2 antigen formaldehyde inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10794",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen formaldehyde inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10803",
                        "description": "The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10989",
                        "description": "The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10990",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB11038",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB11040",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB11041",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB11044",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen propiolactone inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB11603",
                        "description": "The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB11627",
                        "description": "The therapeutic efficacy of Hepatitis B Vaccine Recombinant can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB12568",
                        "description": "The therapeutic efficacy of Tecemotide can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14384",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14385",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14394",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 H1N1 live attenuated antigen can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14445",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 antigen formaldehyde inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14449",
                        "description": "The therapeutic efficacy of Influenza A virus A Perth 16 2009 H3N2 live attenuated antigen can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14619",
                        "description": "The therapeutic efficacy of Influenza A virus A Uruguay 716 2007 H3N2 antigen propiolactone inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14620",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14711",
                        "description": "The therapeutic efficacy of Smallpox Vaccinia Vaccine Live can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB15274",
                        "description": "The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB15461",
                        "description": "The therapeutic efficacy of Yersinia pestis 195 p antigen formaldehyde inactivated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB13924",
                        "description": "The therapeutic efficacy of Varicella Zoster Vaccine Recombinant can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB15483",
                        "description": "The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB15595",
                        "description": "The therapeutic efficacy of Ebola Zaire vaccine live attenuated can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB15654",
                        "description": "The therapeutic efficacy of Moderna COVID 19 Vaccine can be decreased when used in combination with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10317",
                        "description": "The risk or severity of infection can be increased when Rubella virus vaccine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The risk or severity of infection can be increased when Varicella Zoster Vaccine Live attenuated is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10343",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain tice live antigen is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10804",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain connaught live antigen is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB10805",
                        "description": "The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB11003",
                        "description": "The risk or severity of infection can be increased when Anthrax vaccine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB11050",
                        "description": "The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB12386",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain danish 1331 live antigen is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The risk or severity of infection can be increased when BCG vaccine is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14409",
                        "description": "The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl 68578 antigen is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The risk or severity of infection can be increased when Vibrio cholerae CVD 103 HgR strain live antigen is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB14685",
                        "description": "The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Glatiramer may increase the immunosuppressive activities of Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Glatiramer can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of infection can be increased when Glatiramer is combined with Inebilizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}